Studies of drug trials aimed at therapies for Alzheimer’s and other dementias.
- DNA Vaccine Reduces Both Toxic Proteins Linked to Alzheimer’s
- DNA vaccine reduces both toxic proteins linked to Alzheimer’s
- Research article:
Active full-length DNA Aβ42 immunization in 3xTg-AD mice reduces not only amyloid deposition but also tau pathology - A Diabetes Drug Has ‘Significantly Reversed Memory Loss’ in Mice With Alzheimer’s
- Diabetes drug ‘significantly reverses memory loss’ in mice with Alzheimer’s
- Diabetes drug ‘significantly reverses memory loss’ in mice with Alzheimer’s
- Diabetes drug “significantly reverses memory loss” in mice with Alzheimer’s
- Original research article:
Neuroprotective effects of a triple GLP-1/GIP/glucagon receptor agonist in the APP/PS1 transgenic mouse model of Alzheimer’s disease - Montelukast info: m1 m2 m3
- Old rat brains rejuvenated and new neurons grown by asthma drug
- Asthma drug could rejuvenate ageing brains, study suggests
- Dementia cure? Scientists find common asthma drug REJUVENATES ageing brains
- Asthma drug Singulair may be a cure for Alzheimer’s, claims study
- Original research article: Structural and functional rejuvenation of the aged brain by an approved anti-asthmatic drug
- …Successful Clinical Study for Montelukast for the Treatment of Degenerative Diseases of the Brain
- …Initiates Phase 2A Montelukast Versafilm™ Clinical Trial in Alzheimer’s Patients
- The hard truth about Alzheimer’s drugs
- Robert Chen, MD-PhD candidate in Alzheimer’s research: What were the key findings from the Aducanumab phase 1 clinical trials? [Reprinted as: Aducanumab Is Showing Promise As An Alzheimer’s Treatment, But It’s Still Early]
- Drug Restores Cells and Memories in Alzheimer’s: Mouse Study
- Published research:
Silent Allosteric Modulation of mGluR5 Maintains Glutamate Signaling while Rescuing Alzheimer’s Mouse Phenotypes - Experimental Alzheimer’s Drug Shows Anti-Aging Effects
- Experimental drug targeting Alzheimer’s disease shows anti-aging effects
- Published study:
A comprehensive multiomics approach toward understanding the relationship between aging and dementia - Alzheimer’s preventative drug hope
- Potential Alzheimer’s Therapies May Result from Research Into Anti-Cancer Drug, Scientists Say
- Researchers identify ‘neurostatin’ that may reduce the risk of Alzheimer’s disease
- Research publication:
An anticancer drug suppresses the primary nucleation reaction that initiates the production of the toxic Aβ42 aggregates linked with Alzheimer’s disease - Alzheimer’s drug may keep late-stage sufferers out of nursing homes
- Withdrawing dementia drug doubles risk of nursing home placement
- Research publication:
- Nursing home placement in the Donepezil and Memantine in Moderate to Severe Alzheimer’s Disease (DOMINO-AD) trial: secondary and post-hoc analyses
- Roche steps up work on two experimental Alzheimer’s drugs
- Blood pressure medication may lower Alzheimer’s risk
- Blood Pressure and Alzheimer’s Risk: What’s the Connection?
- UPDATED: Eli Lilly offers evidence of twice-failed solanezumab’s impact on Alzheimer’s
- Eli Lilly’s promising Alzheimer’s drug fails in clinical trial
- Breakthrough drug ‘could halt’ Alzheimer’s
- Biogen Alzheimer’s drug exceeds expectations
- Biogen Drug Could Inspire New Hope For Alzheimer’s Treatments
- Is new Alzheimer’s drug a ‘game-changer?’
- Alzheimer’s treatment appears to alleviate memory loss in small trial
- Alzheimer’s treatment appears to alleviate memory loss in small trial [31 August 2016]
- Early Research Shows ‘Hint’ Of Slowing Alzheimer’s, But More Testing Is Needed [August 31, 2016]
- Published study:
The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease - Decline in trials for Alzheimer’s disease
- Experimental drug compound found to reverse effects of Alzheimer’s in mice
- U.S. FDA outlines path to test Alzheimer’s drugs earlier
- The Alzheimer’s Cure That Worked on Mice
- A Novel Phosphatase Inhibitor May Be a STEP Toward Ameliorating Cognitive Dysfunction
- Beta blockers may reduce dementia risk
- Common BP Med May Lower Risk of Dementia
- Alzheimer’s brain plaques ‘rapidly cleared’ in mice
- Eli Lilly to Conduct Additional Study of Alzheimer’s Drug
- Stop selling higher dose Alzheimer’s drug, group says
- F.D.A. Sees Promise in Alzheimer’s Imaging Drug
- For Alzheimer’s patients, antidepressants no better than placebo
- Psoriasis Drugs May Slow Alzheimer’s Dementia
- Drugs approved for Alzheimer’s prevention study
- Alzheimer’s drug IVIg could halt sufferers’ decline
- An Aspirin a Day Slows Cognitive Decline in Certain Women
- Testing a Drug That May Stop Alzheimer’s Before It Starts
- Alzheimer Drug Shows Some Promise in Mild Disease
- Omega-3 may curb memory loss, study says
- Skin cancer drug reverses Alzheimer’s in mice
- Hard to tell, but drug helps as Alzheimer’s progresses
- Cocktail of Popular Drugs May Cloud Brain
- Squirts of Insulin May Help Those With Early Alzheimer’s
- Prescription drugs for Alzheimer’s diseasecom
- Drug Trials Test Bold Plan to Slow Alzheimer’s
- Rare Sharing of Data Leads to Progress on Alzheimer’s
- Drugmakers to share data to speed brain research
- Popular drug for mild Alzheimer’s largely a flop
- Roche Reports Mixed Results in Trial of an Alzheimer’s Drug
- Studies Cast Doubt on Cancer Drug as Alzheimer’s Treatment
